• Markets
    • icon
  • Companies
COV · ASX

CLEO Diagnostics Ltd (ASX:COV)

AU$0.18

 0.0 (0.0%)
ASX:Live
08/12/2023 11:08:44 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

COV Overview

COV Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

COV Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

-5.26%

1 month

-5.26%

YTD

-14.29%

1 year

0%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

COV Announcements

Latest Announcements

Date Announcements

31 August 23

Appendix 4E and Preliminary Financial Report

×

Appendix 4E and Preliminary Financial Report

30 October 23

Quarterly activities and cashflow report

×

Quarterly activities and cashflow report

27 September 23

Annual Report to shareholders

×

Annual Report to shareholders

27 September 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

27 October 23

Restricted securities to be released from escrow

×

Restricted securities to be released from escrow

22 September 23

Notice Required Under ASX Listing Rule 3.13.1

×

Notice Required Under ASX Listing Rule 3.13.1

22 November 23

Results of Annual General Meeting

×

Results of Annual General Meeting

21 September 23

Change of Registry Address

×

Change of Registry Address

19 September 23

Application for quotation of securities - COV

×

Application for quotation of securities - COV

13 October 23

Application for quotation of securities - COV

×

Application for quotation of securities - COV

12 September 23

Restricted securities to be released from escrow

×

Restricted securities to be released from escrow

09 October 23

Cleo Delivers Early Progress on Development Program

×

Cleo Delivers Early Progress on Development Program

06 October 23

Restricted securities to be released from escrow

×

Restricted securities to be released from escrow

06 November 23

Completion of First Triage Test Clinical Validation Study

×

Completion of First Triage Test Clinical Validation Study

06 November 23

Application for quotation of securities - COV

×

Application for quotation of securities - COV

05 October 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

05 October 23

Letter to Shareholders

×

Letter to Shareholders

03 November 23

Pause in Trading

×

Pause in Trading

03 November 23

Trading Halt

×

Trading Halt

02 October 23

Cleo Enhances Board Capacity

×

Cleo Enhances Board Capacity

01 September 23

Letter from the CEO to Shareholders

×

Letter from the CEO to Shareholders

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

COV Shortsell

Frequently Asked Questions

The current share price of CLEO Diagnostics Ltd (COV:ASX) is AU$0.18.
The 52-week high share price for CLEO Diagnostics Ltd (COV:ASX) is AU$0.00.
The 52-week low share price for CLEO Diagnostics Ltd (COV:ASX)? is AU$0.00.
CLEO Diagnostics Ltd (COV:ASX) does not pay a dividend.
CLEO Diagnostics Ltd (COV:ASX) does not pay a dividend.
CLEO Diagnostics Ltd (COV:ASX) does not offer franking credits.
CLEO Diagnostics Ltd (COV:ASX) is classified in the Healthcare.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.